Base Year
Historical Year
Forecast Year
The global immunotherapy drugs market attained a value of USD 222.08 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 11.20% to reach USD 577.42 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
According to the WHO, cancer is the second leading cause of death globally, which led to nearly 10 million deaths in 2020. As a result, the governments and international organisations are increasingly conceptualising initiatives to generate funds while also spreading awareness about various types of cancer and the potential prevention strategies.
These factors are expected to drive the market growth in the coming years. Additionally, the increased expenditure in the healthcare sector and the accessibility to efficient therapeutic techniques, including target-specific and tailored treatments, are also projected to propel the global immunotherapy drugs industry further. Immunotherapy boosts the body’s natural defences to combat the disease by aiding the immune system to recognise and attack cancerous cells.
Geographically, North America is anticipated to account for a significant market share of the immunotherapy drugs industry. This can be attributed to the rising geriatric population in the region and the availability of improved medical facilities.
Immunotherapy is a type of biological therapy, which is used as a treatment for cancer and helps patients fight cancer by providing a boost to the immune system's natural defences to locate and attack cancer cells in the body. Some of the drugs used in immunotherapy are Ipilimumab (Yervoy®), Pembrolizumab (Keytruda®), Nivolumab (Opdivo®), and Atezolizumab (Tecentriq®), among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major types of immunotherapy drugs are:
The market can be broadly categorised, on the basis of therapy area, into:
The EMR report looks into the regional markets of immunotherapy drugs like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The immunotherapy drugs industry is anticipated to witness growth in both developed as well as developing nations. This can be associated with the rising geriatric population and increasing incidences of chronic illnesses worldwide. Additionally, the increasing expenditure by the leading pharmaceutical companies in the research and development of efficient immunotherapy medications is estimated to propel the industry growth. Furthermore, the growing investments by the governments in the development of healthcare infrastructure are further projected to positively stimulate the market growth in the coming years. Moreover, the market is further expected to be fuelled by the rapid technological advancements in the pharmaceutical industry.
The report presents a detailed analysis of the following key players in the global immunotherapy drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Applications |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the global immunotherapy drugs market attained a value of nearly USD 222.08 billion.
The market is projected to grow at a CAGR of 11.20% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 577.42 billion by 2032.
The major drivers of the industry, such as the rising expenditure in the healthcare industry, rising consciousness pertaining to the availability of cancer treatments, increasing research and development activities, and rapidly growing geriatric global population, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the increased prevalence of cancer cases worldwide.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant types of immunotherapy drugs in the industry are monoclonal antibodies, vaccines, interferons alpha and beta, and interleukins, among others.
The significant market divisions, based on therapy areas, include cancer, autoimmune and inflammatory diseases, and infectious diseases, among others.
The major players in the industry are AbbVie Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline PLC, and F. Hoffmann-La Roche AG, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share